Research area A

NUTRIENT UPTAKE AND METABOLISM

During the pathogenic blood phase of the complex life cycle Plasmodium spends >99.9% of its life cycle inside host cells. This obligate intracellular niche in an extreme environment (i.e. terminally differentiated erythrocytes) requires metabolic adaptations, which until to date form the basis for antimalarial chemotherapy. This is exemplified by the drug chloroquine that inhibits non-toxic (host-derived) hemoglobin degradation in the parasite food vacuole. In this research area four projects examine the strict dependence of the parasite on external nutrient supply, ranging from ions to complex lipids.


Projects

Project A1 - 1st Cohort

Conserved and Lineage-specific Functions of Plasmodium Membrane Transport Proteins

 

KAI MATUSCHEWSKI (HUB) in partnership with Alexander Maier (ANU)

 

In this project a systematic experimental genetics analysis of candidate membrane transport proteins that are shared amongst apicomplexan parasites or unique to distinct Plasmodium species will identify and prioritize candidate drug targets. Lipids are often overlooked as some of the most important and versatile principal cellular components.

Francois Korbmacher

 

Project A1 - 2nd Cohort

Conserved and Lineage-specific Functions of Plasmodium Membrane Transport Proteins

 

KAI MATUSCHEWSKI (HUB) in partnership with Alexander Maier (ANU)

 

An intracellular life style and population expansion strictly depends on efficient uptake of ions, nutrients, building blocks and membrane lipids. Mammalian Plasmodium parasites have very tight host species barriers and co-evolved with their respective hosts. Work in two Plasmodium parasite models, the murine malaria model P. berghei and P. falciparum blood cultures, combines phenotyping of the entire parasite life cycle and parasite/host cross-talk during infection with in-depth analysis of blood infection by the human human pathogen. These studies are expected to uncover druggable targets and generate virulence attenuated parasite lines for preclinical testing of malaria vaccine strategies.

Frederik Huppertz

 

 



Project A2 - 1st Cohort

Plasmodium falciparum lipid metabolism as a target for malaria intervention strategies

 

ALEXANDER MAIER (ANU) in partnership with Edda Klipp and Kai Matuschewski (HUB)

 

The project will combine state-of-the-art lipidomics analyses of synchronized and selected parasite stages with mathematical modelling of lipid fluxes in order to select key enzymes and transporters that can be validated experimentally. An integrated mathematical model for ion and cell volume homeostasis in the malaria parasite-infected human erythrocyte remains elusive.

Merryn Fraser

Project A2 - 2nd Cohort

Lipids as targets for antimalarial drugs

 

ALEXANDER MAIER (ANU) in partnership with Kai Matuschewski (HUB), Edda Klipp (HUB), Elena Levashina (MPIIB)

 

Lipids – together with proteins and nucleid acids – are the major building blocks of cells. We have recently determined the lipid composition of the different life cycle stages of Plasmodium falciparum and Plasmodium berghei. Based on this data we will now determine key molecules that are important for lipid import and metabolism and explore their role and potential as drug targets. A bioinformatic overview obtained in silico will guide us to identify rate limiting steps in the lipid metabolism. These predictions will be verified using transgenic approaches using CRISPR/Cas9 and various tagging strategies. Our approaches will also determine the localization, function and importance of these enzymes and transporters for the survival of the malaria parasites.

TBD



Project A3 - 1st Cohort

An integrated thermodynamic model of ion homeostasis in the malaria parasite

 

EDDA KLIPP (HUB) in partnership with KIARAN KIRK (ANU) and Adele Lehane (ANU)

 

The project entails obtaining quantitative biochemical and physiological data and incorporating these into a quantitative description of ion homeostasis in the intracellular malaria parasit.  The model will contribute to an understanding of the mechanism-of-action of ‘ion-disrupting’ antimalarials that are emerging as priority drug candidates in the malaria-medicine pipeline.

Jorin Diemer

Project A3 - 2nd Cohort

TBA

 

EDDA KLIPP (HUB) in partnership with Alexander Maier (ANU)

 

Lipids – together with proteins and nucleid acids – are the major building blocks of cells. We have recently determined the lipid composition of the different life cycle stages of Plasmodium falciparum and Plasmodium berghei. Based on this data we will now determine key molecules that are important for lipid import and metabolism and explore their role and potential as drug targets. A bioinformatic overview obtained in silico will guide us to identify rate limiting steps in the lipid metabolism. These predictions will be verified using transgenic approaches using CRISPR/Cas9 and various tagging strategies. Our approaches will also determine the localization, function and importance of these enzymes and transporters for the survival of the malaria parasites.

Maxim Karnetzki



Project A5 - 2nd Cohort

Role of host lipids in the establishment of the human malaria parasite in the mosquito 

 

ELENA LEVASHINA (MPI) in partnership with Alexander Maier (ANU) and Martin Blume (RKI)

 

Establishment of Plasmodium falciparum in the mosquito is essential for malaria transmission. However, the host and mosquito factors that regulate the first steps of this critical process are not well understood. P. falciparum transmission stages represent an interesting evolutionary model of plasticity as they require a rapid parasite adaptation to fundamentally different environments (e.g. temperature, metabolites, immune system). The biological mechanisms that underlie parasite plasticity that deals with changing environment, however, remain unknown.

Alexander Penning